Last reviewed · How we verify
Aplisol@ PPD material — Competitive Intelligence Brief
phase 2
Purified protein derivative
Infectious Disease
Biologic
Live · refreshed every 30 min
Target snapshot
Aplisol@ PPD material (Aplisol@ PPD material) — JHP Pharmaceuticals LLC. Aplisol is a purified protein derivative (PPD) used as a skin test to diagnose tuberculosis infection.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Aplisol@ PPD material TARGET | Aplisol@ PPD material | JHP Pharmaceuticals LLC | phase 2 | Purified protein derivative |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Purified protein derivative class)
- JHP Pharmaceuticals LLC · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Aplisol@ PPD material CI watch — RSS
- Aplisol@ PPD material CI watch — Atom
- Aplisol@ PPD material CI watch — JSON
- Aplisol@ PPD material alone — RSS
- Whole Purified protein derivative class — RSS
Cite this brief
Drug Landscape (2026). Aplisol@ PPD material — Competitive Intelligence Brief. https://druglandscape.com/ci/aplisol-ppd-material. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab